News about Global Pharma

FDA Approves GenFleet's GFH925 Phase III Trial for Colorectal Cancer

The primary objective is to compare the efficacy of GFH925 versus the current standard of care.

Global Pharma | 20/04/2024 | By Abha |  834

Nora Pharma Gets Health Canada Approval for Commercializing NIOPEG

Nora Pharma has received approval for its first Biosimilar product.

Global Pharma | 20/04/2024 | By Aishwarya |  937

Cochlear Limited Expands Access to Osia System for Children as Young as 5

The Osia System is a new category of bone conduction hearing solutions that uses digital piezoelectric stimulation to bypass damaged areas of the natural hearing system to send sound vibrations directly to the inner ear (cochlea).

Global Pharma | 20/04/2024 | By Abha |  433

Dr. Reddys Laboratories Unveils DailyBloom IBS Program to Manage IBS

Dr. Reddy’s Laboratories Ltd. has introduced its condition management program DailyBloom IBS, an integrated care plan for Irritable Bowel Syndrome (IBS).

Global Pharma | 20/04/2024 | By Aishwarya |  729

BioCryst Announces Approval of ORLADEYO from Brazilian Health Regulatory Agency

BioCryst Pharmaceuticals has announced that the Brazilian Health Regulatory Agency (ANVISA) has granted approval for oral, once-daily ORLADEYO (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults.

Global Pharma | 20/04/2024 | By Aishwarya |  518

ENTOD Pharma Gets CDSCO Approval for PresVu to Treat Age-Related Vision Impairment

ENTOD Pharmaceuticals has gained approval from the Central Drugs Standard Control Organisation (CDSCO) for PresVu to treat age-related vision impairment.

Global Pharma | 19/04/2024 | By Aishwarya |  1041

Scopio Labs Receives FDA Clearance for Full-Field Bone Marrow Aspirate Application

This clearance establishes a new regulatory category for all-digital bone marrow aspirate analysis software, heralding a transformative era in hematologic diagnostics.

Global Pharma | 19/04/2024 | By Abha |  580

Jubilant Generics Limited's Roorkee Facility Receives VAI Classification from USFDA

This classification signifies that the facility is deemed to be in an acceptable state of compliance with current good manufacturing practices (cGMP).

Global Pharma | 19/04/2024 | By Abha |  820

CDSCO Issues Guidelines to Curb Circulation of Substandard Pharmaceuticals

Central Drugs Standard Control Organisation (CDSCO) has recently issued draft guidelines on good distribution practices to curb the introduction of spurious, adulterated and sub-standard pharmaceutical products in the market.

Global Pharma | 19/04/2024 | By Aishwarya |  1205

Biocon Signs Exclusive Licensing and Supply Deal with Biomm for Drug Commercialization

Biocon Limited has signed an exclusive licensing and supply agreement with Biomm to commercialize its vertically integrated drug product, Semaglutide (gOzempic).

Global Pharma | 19/04/2024 | By Aishwarya |  742